arrow
E

Esther Pérez-Herrán

Tres Cantos
H指数:30
被引数:3,889

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Alpibectir–Ethionamide combination (AlpE) for the treatment of tuberculosis

Alpibectir–Ethionamide组合(AlpE)用于治疗结核病

2026-04-070
OAAI
Preserved efficacy of lyophilized SARS-CoV-2 mRNA vaccine incorporating novel ionizable lipids after one year at 25 °C

在25 °C条件下储存一年后,采用新型可电离脂质包封的冻干SARS-CoV-2 mRNA疫苗仍保持有效。

2025-07-010
OAAI
Sanfetrinem, an oral (3-lactam antibiotic repurposed for the treatment of tuberculosis

Sanfetrinem,一种用于治疗结核病的口服β-内酰胺类抗生素。

2025-05-010
OAAI
Lysyl-tRNA synthetase, a target for urgently needed M. tuberculosis drugs
2022-10-1113
OAAI
GSK2556286 Is a Novel Antitubercular Drug Candidate Effective In Vivo with the Potential To Shorten Tuberculosis Treatment
2022-06-2128
OA
The small-molecule SMARt751 reverses Mycobacterium tuberculosis resistance to ethionamide in acute and chronic mouse models of tuberculosis

小分子SMARt751在急性和慢性结核病小鼠模型中逆转结核分枝杆菌对乙硫酰胺的耐药性

2022-05-0419
OA
Inhibiting the stringent response blocks Mycobacterium tuberculosis entry into quiescence and reduces persistence
2019-03-0196
OAAI
Easy-To-Synthesize Spirocyclic Compounds Possess Remarkable in Vivo Activity against Mycobacterium tuberculosis
2018-11-2022
OAAI
Discovery of a Potent and Specific M-tuberculosis Leucyl-tRNA Synthetase Inhibitor: (S)-3-(Aminomethyl)-4-chloro-7-(2hydroxyethoxy)benzo[c][1,2]oxaborol-1(3H)-ol (GSK656)
2017-09-27133
PREAI
Discovery of Novel Oral Protein Synthesis Inhibitors of Mycobacterium tuberculosis That Target Leucyl-tRNA Synthetase
2016-10-0199
OAAI